Respiratory medicine

2016 ◽  
Keyword(s):  
Lung Diseases ◽  
Cor Pulmonale ◽  
Sleep Apnoea ◽  
Respiratory Medicine ◽  
Chronic Obstructive ◽  
Basic Training ◽  
Allergic Alveolitis ◽  
Obstructive Pulmonary Disease ◽  
Obstructive Sleep ◽  
Occupational Lung Diseases

Chapter 18 covers the basic science and clinical topics relating to respiratory medicine which trainees are required to learn as part of their basic training and demonstrate in the MRCP. The chapter starts with an introduction to the respiratory system, before covering respiratory defence and physiology, respiratory investigations, respiratory failure, pneumonia, tuberculosis, cystic fibrosis, bronchiectasis, pleural effusion, chronic obstructive pulmonary Disease, adult respiratory distress syndrome, asthma , fungal lung diseases, pulmonary embolism , lung cancer, pulmonary fibrosis, extrinsic allergic alveolitis, occupational lung diseases, sarcoidosis, Cor pulmonale and pulmonary hypertension, pneumothorax, cough and haemoptysis, pulmonary eosinophilia, and obstructive sleep apnoea.

Chest medicine

2017 ◽  
pp. 160-201
Author(s):  
Ian B. Wilkinson ◽  
Tim Raine ◽  
Kate Wiles ◽  
Anna Goodhart ◽  
Catriona Hall ◽  
...  
Keyword(s):  
Respiratory Health ◽  
Cor Pulmonale ◽  
Sleep Apnoea ◽  
Obstructive Sleep Apnoea Syndrome ◽  
Chronic Obstructive ◽  
Allergic Alveolitis ◽  
Obstructive Pulmonary Disease ◽  
Industrial Dust ◽  
Obstructive Sleep ◽  
Bedside Tests

This chapter explores chest medicine, including respiratory health, bedside tests in chest medicine, further investigations in chest medicine, pneumonia, bronchiectasis, cystic fibrosis (CF), lung tumours, fungi and the lung, asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), respiratory failure, pulmonary embolism (PE), pneumothorax, pleural effusion, obstructive sleep apnoea syndrome, cor pulmonale, sarcoidosis, interstitial lung disease (ILD), extrinsic allergic alveolitis (EAA), idiopathic pulmonary fibrosis (IPF), and industrial dust diseases.

Respiratory medicine

2020 ◽  
pp. 263-310
Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Nazia Hussain ◽  
Emma Nash ◽  
...  
Keyword(s):  
General Practice ◽  
Lung Disease ◽  
Asthma Management ◽  
Sleep Apnoea ◽  
Respiratory Medicine ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Occupational Lung Disease ◽  
Obstructive Sleep ◽  
Diffuse Parenchymal Lung Disease

This chapter in the Oxford Handbook of General Practice explores respiratory medicine in general practice. It covers breathlessness, cough, chest signs, and other signs of respiratory disease. It examines asthma in adults, bronchodilators and steroids, asthma management in practice, and drug treatment of asthma, as well as chronic obstructive pulmonary disease (COPD) and acute exacerbations of COPD. It discusses lung cancer, colds and influenza, pneumonia, tuberculosis, cystic fibrosis and Kartagener syndrome, diffuse parenchymal lung disease, occupational lung disease, and snoring and obstructive sleep apnoea.

Respiratory

2019 ◽  
pp. 35-60
Author(s):  
Tanya M. Monaghan ◽  
James D. Thomas
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cystic Fibrosis ◽  
Pleural Effusion ◽  
Superior Vena ◽  
Vena Cava ◽  
Cor Pulmonale ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Obstructive Sleep

This chapter is about respiratory system, and covers chronic obstructive pulmonary disease, interstitial lung disease, lobectomy, pleural effusion, pneumothorax, tuberculosis, pneumonia, obstructive sleep apnoea, cystic fibrosis, Kartagener’s syndrome, bronchiectasis, superior vena cava obstruction, and cor pulmonale.

The state of the cardiovascular system in occupational bronchitis and chronic obstructive pulmonary disease, not associated with the impact of harmful industrial factors

2021 ◽  
pp. 55-68
Author(s):  
Vyacheslav S. Lotkov ◽  
Anton Vladimirovich Glazistov ◽  
Antonina G. Baykova ◽  
Marina Yuryevna Vostroknutova ◽  
Natalia E. Lavrentieva
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cardiovascular System ◽  
Pulmonary Disease ◽  
Lung Diseases ◽  
Chronic Obstructive ◽  
External Respiration ◽  
Obstructive Pulmonary Disease ◽  
Occupational Lung Diseases ◽  
The Right ◽  
The Impact

The formation and progression of chronic dust bronchitis and chronic bronchitis of toxic-chemical etiology, chronic obstructive pulmonary disease is accompanied by an increase in the degree of ventilation disorders, echocardiographic signs of hypertrophy and dilatation of the right ventricle are formed, typical for chronic pulmonary heart disease. The progression of disturbances in the function of external respiration in dusty lung diseases leads to a decrease in myocardial contractility. The detection of hemodynamic disturbances at the early stages of the development of occupational lung diseases indicates the need for individual monitoring of the functional state of the cardiovascular system in the process of contact with industrial aerosols, especially in groups of workers with long-term exposure.

Atrial fibrillation and sleep apnoea and chronic obstructive pulmonary disease

ESC CardioMed ◽  
2018 ◽  
pp. 2235-2237
Author(s):  
Tauseef Akhtar ◽  
Jared D. Miller ◽  
Hugh Calkins
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Risk Factor Modification ◽  
Obstructive Sleep ◽  
P Rate

Rate control, rhythm control, and anticoagulation are well entrenched as the three central pillars of atrial fibrillation (AF) management. Risk factor modification of other associated co-morbidities is now emerging as a critical fourth pillar in the prevention and management of AF. Obstructive sleep apnoea and chronic obstructive pulmonary disease, in particular, have important implications in the development of AF and appropriate selection of therapy. This chapter reviews the pathophysiology and clinical evidence linking these conditions with AF. In addition, it discusses important considerations in the management of concurrent AF and obstructive sleep apnoea or chronic obstructive pulmonary disease.

Atrial fibrillation and sleep apnoea and chronic obstructive pulmonary disease

ESC CardioMed ◽  
2018 ◽  
pp. 2235-2237
Author(s):  
Jared D. Miller ◽  
Hugh G. Calkins
Keyword(s):  
Atrial Fibrillation ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Risk Factor Modification ◽  
Obstructive Sleep ◽  
P Rate

Rate control, rhythm control, and anticoagulation are well entrenched as the three central pillars of atrial fibrillation (AF) management. Risk factor modification of other associated co-morbidities is now emerging as a critical fourth pillar in the prevention and management of AF. Obstructive sleep apnoea and chronic obstructive pulmonary disease, in particular, have important implications in the development of AF and appropriate selection of therapy. This chapter reviews the pathophysiology and clinical evidence linking these conditions with AF. In addition, it discusses important considerations in the management of concurrent AF and obstructive sleep apnoea or chronic obstructive pulmonary disease.

Sign in / Sign up

Export Citation Format

Share Document